TBXU Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 8.28%, SMA50 9.71%, SMA200 14.99%). The stock’s 14-day RSI is 64.07 (firm momentum), while the ATR of 0.81 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -9.53% below its high and over 36.84% above its low. Average 10-day trading volume of 687.88 shares is below the 3-month average of 3.79 thousand, indicating normal recent market interest.

Our AI price prediction model suggests that Direxion Shares ETF Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.

Direxion Shares ETF Trust last paid a dividend of 0.41 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Direxion Shares ETF Trust (AMEX:TBXU) closed at $34.81 USD, losing -$0.51 (-1.45%) from the previous close of $35.32. The stock is currently mid-range between its 52-week high and low $25.71 and $38.89. With a market capitalization of about $3.48 million, Direxion Shares ETF Trust is classified as a micro-cap and shows higher-than-market volatility (beta ~3.58). Key stats such as the average daily volume over the past year has been around 3.80 thousand shares, volume is running light vs its 52-week average. Headquartered in None, None, Direxion Shares ETF Trust operates in the Healthcare sector and the Biotechnology industry. The fund seeks daily investment results (before fees and expenses) of 200% of the daily performance of the NYSE Biotechnology Top 5 Equal Weight Index.